Article
Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders.
Viruses - 11 Nov 2022
Wedemeyer Heiner, Di Marco Vito, Garcia-Retortillo Montserrat, Teti Elisabetta, Fraser Chris, Morano Amado Luis Enrique, Rodriguez-Tajes Sergio, Acosta-López Silvia, O'Loan Joss, Milella Michele, Buti Maria, Guerra-Veloz María Fernanda, Ramji Alnoor, Fenech Mary, Martins Alexandra, Borgia Sergio M, Vanstraelen Kim, Mertens Michael, Hernández Cándido, Ntalla Ioanna, Ramroth Heribert, Milligan Scott
Abstract excerpt
Hepatitis C virus (HCV) is prevalent in people with mental health disorders, a priority population to diagnose and cure in order to achieve HCV elimination. This integrated analysis pooled data from 20 cohorts in seven countries to evaluate the real-world effectiveness of the pangenotypic direct-acting antiviral (DAA) sofosbuvir/velpatasvir (SOF/VEL) in people with mental health disorders. HCV-infected patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
